Trial intelligence / Profile preview

Tinefcon in Plaque Psoriasis

NCT01373567Phase 4Completed

Sponsor
Piramal Enterprises Limited
Start
Dec 2010
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Tinefcon in plaque psoriasis, sponsored by Piramal Enterprises Limited. Started Dec 2010; status: completed.

02

Drugs

Tinefcon
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT01373567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01373567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call